Foldrx Pharmaceuticals logo

Foldrx Pharmaceuticals

FoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases

2 employees · est. 2003

VS
Wren Therapeutics logo

Wren Therapeutics

Stopping the wave of neurodegeneration at its source

34 employees · est. 2016 · Cambridge, United Kingdom

Foldrx Pharmaceuticals is the older company (2003 vs 2016); Wren Therapeutics is the larger of the two.

Side-by-Side Comparison

Foldrx Pharmaceuticals Wren Therapeutics
Founded
2003 older 2016
Headquarters
Not tracked yet Cambridge, United Kingdom
Employees
2 34 larger
Industry
Not tracked yet Biopharma, Biotechnology, Health Care
Funding Stage
Acquired Series Unknown
Total Funding
$72.00M $30.40M
Funding Rounds
4 3
Services
online 4D lottery services, fast and stable server access, 24/7 customer support, high winrate lotteries, data security and privacy Not tracked yet
Target Customers
togel enthusiasts, mobile users, gamblers on-the-go, travellers during seasonal migration Not tracked yet
Taxonomy
Protein Misfolding Diseases, Disease-modifying Drug Therapies, Small Molecule Therapeutics, Genetic Neurologic Disorders, Cardiovascular Disorders, Transthyretin-associated Amyloidoses, TTR-associated Amyloidoses, Polyneuropathy, Cardiomyopathy, Amyloidosis, Parkinson's Disease, Cystic Fibrosis, Drug Discovery, Clinical Development, Protein Folding Neurodegenerative Diseases, Biopharmaceutical Company, Drug Discovery, Protein Misfolding Diseases, Small-molecule Therapeutics, Parkinson's Disease, Alzheimer's Disease, ALS, Wren Therapeutics, Cambridge UK, New Technology Platform, Protein Intermediates, Oligomers, Rare Disorders, University Of Cambridge
Website
foldrx.com wrentherapeutics.com
Foldrx Pharmaceuticals logo

About Foldrx Pharmaceuticals

FoldRx Pharmaceuticals, founded in 2003, is a pioneering biopharmaceutical company focused on the discovery and development of disease-modifying drug therapies for protein misfolding diseases. Their mission, encapsulated in their slogan, aims at addressing the critical challenge of protein folding,...

Wren Therapeutics logo

About Wren Therapeutics

Wren Therapeutics is a biopharmaceutical company that has transformed drug discovery for neurodegenerative diseases through its platform, WaveBreak. This platform targets protein intermediates central to disease pathways, specifically focusing on the oligomers that are beyond the reach of convention...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Foldrx Pharmaceuticals and Wren Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Foldrx Pharmaceuticals and Wren Therapeutics — by email.

Frequently Asked Questions

Foldrx Pharmaceuticals — FoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases. Wren Therapeutics — Stopping the wave of neurodegeneration at its source. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Foldrx Pharmaceuticals has raised $72.00M while Wren Therapeutics has raised $30.40M.
Foldrx Pharmaceuticals and Wren Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Foldrx Pharmaceuticals with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy